Paloma Acquisition Corp I — Q3 2026 Form 10-Q
Business context and period. For the quarter and nine months ended September 30, 2026. Paloma is a Cayman Islands blank-check company formed to pursue a business combination; it had not commenced operations or identified a completed transaction in the filing. It has 24 months from its February 20, 2026 IPO closing to complete a business combination, subject to an earlier board-approved liquidation date.
Financial highlights
| Metric | Three months ended September 30, 2026 | Nine months ended September 30, 2026 |
|---|---|---|
| Operating revenue | None | None |
| Net income | $1.14 million | $1.35 million |
| Interest income from trust investments | $1.52 million | $3.61 million |
| General and administrative expense | $376,846 | $862,852 |
| Share-based compensation expense | None reported for the quarter | $1.45 million |
| Operating cash flow | Not presented for the quarter | $(642,779) |
- Net income per Class A and Class B share was $0.05 for the quarter and $0.08 for the nine-month period. Profitability reflects trust interest, not operating activity; operating margins are not meaningful because the company has no revenue.
- At September 30, assets were $169.27 million, including $168.11 million in the trust account and $1.01 million in cash outside it. Trust assets were invested in a U.S. Treasury money market fund. Redeemable Class A shares totaled 16.45 million, carried at $168.11 million, or $10.22 per share.
- Working capital was $914,645. Total liabilities were $7.04 million, including a $6.58 million deferred underwriting fee payable only if a business combination closes and $250,000 of deferred legal fees that are payable regardless of whether one closes. No loans were outstanding at quarter-end.
- Nine-month cash flows included $164.50 million invested in the trust account and $166.15 million of financing cash inflows; cash outside the trust ended at $1.01 million.
Changes, outlook and risks
- The IPO and partial over-allotment in February raised $164.50 million from public units; private placements raised $5.29 million. The company had no comparable IPO or trust assets at December 31, 2025. The prior-year income comparison is only from inception through September 30, 2025, before the IPO, and is not directly comparable.
- Management said it believes available funds are sufficient for working capital needs for one year and does not currently expect to need additional funds for operations. It cautioned that higher-than-estimated search, diligence or deal costs could leave insufficient operating cash; additional financing may also be needed to close a transaction or address significant redemptions. No earnings or transaction guidance was provided.
- Key risks include failure to complete a business combination within the completion window, market and economic disruptions, and creditor claims against trust assets. The sponsor has agreed to certain trust-protection indemnities, but the company has not verified the sponsor’s ability to meet them and believes its assets consist of company securities.
- Unusual related-party items include $1.45 million of share-based compensation for director nominees and CFO consulting costs of $69,231 for the nine months, recorded as expense with an offsetting capital contribution. The company also incurred $73,214 of administrative services fees during the period.
- No legal proceedings or material changes to previously disclosed risk factors were reported. Management concluded disclosure controls were effective; no material change in internal control was reported. No subsequent events requiring adjustment or disclosure were identified.
Investor verification checklist
- Verify the target-search status, transaction timetable and remaining time before the February 2028 completion deadline.
- Review the trust balance, redemption value per share and potential redemptions or financing needs if a transaction is proposed.
- Confirm the cash runway against ongoing expenses and deferred legal, underwriting and related-party obligations.
- Assess sponsor indemnity capacity, creditor-claim exposure, and potential dilution from founder shares, warrants or future financing.
- Review related-party arrangements and the valuation and vesting assumptions underlying share-based compensation.